Cogent Biosciences, Inc.

COGT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001622229

SEC filings (opens in a new tab)

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Cogent Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of COGT: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	73	1	82	+10
Shares	36.8M	327.3K	44.9M	+8.43M (+23.1%)
Value	$309.6M	$2.75M	$385.2M	+$78.3M (+25.5%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Cogent Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to COGT in Q4 2021
Institution	Shares	Value	% of portfolio
Eventide Asset Management, LLC	3,514,909	$30.2M	0.39%
TCG Crossover Management, LLC	2,750,037	$23.6M	11.05%
Frazier Management LLC	1,774,891	$15.2M	1.17%
Marshall Wace, LLP	1,002,250	$8.60M	0.02%
Atlas Venture Life Science Advisors, LLC	222,976	$1.91M	0.18%
Kynam Capital Management, LP	150,000	$1.29M	0.69%
Atom Investors LP	61,360	$526.0K	0.15%
Millennium Management LLC	50,175	$431.0K	0.00%
Sender Co & Partners, Inc.	48,861	$419.0K	0.27%
Alps Advisors Inc	46,116	$396.0K	0.00%
Dimensional Fund Advisors LP	43,001	$369.0K	0.00%
D. E. Shaw & Co., Inc.	25,813	$221.0K	0.00%
Wexford Capital LP	20,000	$172.0K	0.02%
Jump Financial, LLC	16,200	$139.0K	0.01%
ProShare Advisors LLC	13,734	$118.0K	0.00%
Squarepoint Ops LLC	10,475	$90.0K	0.00%
Quantbot Technologies LP	2,800	$24.0K	0.00%
High Net Worth Advisory Group LLC	1,500	$13.0K	0.00%
Point72 Hong Kong Ltd	788	$7.00K	0.00%
Allspring Global Investments Holdings, LLC	892	$7.00K	0.00%
Daiwa Securities Group Inc.	116	$1.00K	0.00%
Simplex Trading, LLC	100	$0	0.00%
FinTrust Capital Advisors, LLC	50	$0	0.00%

Sold out (13)

Institutions that held Cogent Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of COGT in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Polar Capital Holdings Plc	1,228,828	$10.3M
Bank of Montreal	131,757	$1.16M
Moore Capital Management, LP	118,266	$995.0K
Qube Research & Technologies Ltd	38,213	$321.0K
Ikarian Capital, LLC	30,727	$258.0K
SG Americas Securities, LLC	19,307	$162.0K
Citadel Advisors LLC	14,340	$121.0K
Capstone Investment Advisors, LLC	12,928	$109.0K
Trexquant Investment LP	11,407	$96.0K
STRS Ohio	8,600	$72.0K
Red Tortoise LLC	342	$5.00K
Tarbox Family Office, Inc.	278	$2.00K
UBS Group AG	258	$2.00K

Not filed for Q4 2021 yet (1)

Institutions that held Cogent Biosciences, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding COGT in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Marshall Wace North America L.P.	327,332	$2.75M